Greetje J Tack

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. doi request reprint Tioguanine in the treatment of refractory coeliac disease--a single centre experience
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
    Aliment Pharmacol Ther 36:274-81. 2012
  2. pmc Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, Amsterdam 1007 MB, The Netherlands
    BMC Gastroenterol 12:159. 2012
  3. doi request reprint Origin and immunophenotype of aberrant IEL in RCDII patients
    Greetje J Tack
    Gastroenterology and Hepatology, VU University Medical Center, The Netherlands
    Mol Immunol 50:262-70. 2012
  4. doi request reprint The spectrum of celiac disease: epidemiology, clinical aspects and treatment
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Nat Rev Gastroenterol Hepatol 7:204-13. 2010
  5. doi request reprint Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    Bone Marrow Transplant 46:840-6. 2011
  6. pmc Evaluation of Cladribine treatment in refractory celiac disease type II
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    World J Gastroenterol 17:506-13. 2011
  7. pmc Update on the diagnosis and management of refractory coeliac disease
    Petula Nijeboer
    Department of Gastroenterology, VU University Medical Center, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands
    Gastroenterol Res Pract 2013:518483. 2013

Detail Information

Publications7

  1. doi request reprint Tioguanine in the treatment of refractory coeliac disease--a single centre experience
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
    Aliment Pharmacol Ther 36:274-81. 2012
    ..Besides corticosteroids, azathioprine has been advocated for the treatment of refractory coeliac disease type I. However, tioguanine (TG) might be better tolerated and more efficacious owing to a simpler metabolism towards bioactivation...
  2. pmc Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, Amsterdam 1007 MB, The Netherlands
    BMC Gastroenterol 12:159. 2012
    ..Invasive techniques are still required to distinguish between uncomplicated and complicated forms of CD...
  3. doi request reprint Origin and immunophenotype of aberrant IEL in RCDII patients
    Greetje J Tack
    Gastroenterology and Hepatology, VU University Medical Center, The Netherlands
    Mol Immunol 50:262-70. 2012
    ..The aim of this study was to gain further insight in the origin and characteristics of aberrant IELs by analysing T-cell receptor (TCR) rearrangements, and by immunophenotypic analysis of aberrant IELs...
  4. doi request reprint The spectrum of celiac disease: epidemiology, clinical aspects and treatment
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Nat Rev Gastroenterol Hepatol 7:204-13. 2010
    ..This complication is referred to as refractory celiac disease, and imposes a serious risk of developing a virtually lethal enteropathy-associated T-cell lymphoma...
  5. doi request reprint Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    Bone Marrow Transplant 46:840-6. 2011
    ..5 months. EATL was observed in one transplanted patient, only after 4 years of follow-up. Auto-SCT after conditioning with high-dose chemotherapy in RCD II patients unresponsive to cladribine therapy is feasible and seems promising...
  6. pmc Evaluation of Cladribine treatment in refractory celiac disease type II
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    World J Gastroenterol 17:506-13. 2011
    ..To evaluate cladribine [2-chlorodeoxyadenosine (2-CdA)] therapy in refractory celiac disease (RCD) II...
  7. pmc Update on the diagnosis and management of refractory coeliac disease
    Petula Nijeboer
    Department of Gastroenterology, VU University Medical Center, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands
    Gastroenterol Res Pract 2013:518483. 2013
    ..This paper describes the clinical characteristics of RCDI and RCDII, diagnostic approach, and the latest insights in treatment options...